Safety and efficiency of ventricular pacing prevention with an aai-ddd changeover mode in patients with sinus node disease or atrioventricular block: impact on battery longevity—a sub-study of the answer trial

HIGHLIGHTS

• who: Europace ( and colleagues from the Department of Cardiology and Angiology, Charité University Hospital, Berlin, Germany have published the research: Safety and efficiency of ventricular pacing prevention with an AAI-DDD changeover mode in patients with sinus node disease or atrioventricular block: impact on battery longevity—a sub-study of the ANSWER trial, in the Journal: (JOURNAL) of 14/05/2015
• what: This trial shows that the use of SafeR to reduce VP in a general dual-chamber pacemaker population, comprising similarly sized subgroups of SND and atrioventricular block (AVB) patients, is effective and safe . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.